$14.44
-0.34-2.30%
Pre-Market: 7:50 AM EDT
Comments
Loading...
Arcutis Biotherapeutics Earnings Estimates, EPS & Revenue | NASDAQ:ARQT | Benzinga
Arcutis Biotherapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 13
EPS Estimate
$-0.340
Quarterly Revenue Estimate
$56.26M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$196.54M
Analyze the earnings history of Arcutis Biotherapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Arcutis Biotherapeutics (ARQT) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-25 | $-0.09 | $-0.27 | 66.7 % |
| Q3 | 2024-11-06 | $-0.33 | $-0.42 | 21.4 % |
| Q2 | 2024-08-14 | $-0.42 | $-0.57 | 26.3 % |
| Q1 | 2024-05-14 | $-0.32 | $-0.73 | 56.2 % |
Arcutis Biotherapeutics (ARQT) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-25 | $71.36M | $57.75M | 23.6 % |
| Q3 | 2024-11-06 | $44.76M | $37.62M | 19.0 % |
| Q2 | 2024-08-14 | $30.86M | $27.12M | 13.8 % |
| Q1 | 2024-05-14 | $49.57M | $14.68M | 237.7 % |
FAQ
When is Arcutis Biotherapeutics (NASDAQ:ARQT) reporting earnings?
Arcutis Biotherapeutics (ARQT) is scheduled to report earnings on May 13, 2025. The last reported earnings were for reported on February 25, 2025 for Q4.
What were the latest earnings per share (EPS) for Arcutis Biotherapeutics (NASDAQ:ARQT)?
The Actual EPS was $-0.09, which beat the estimate of $-0.27.
What were Arcutis Biotherapeutics’s (NASDAQ:ARQT) revenues?
The Actual Revenue was $71.4M, which beat the estimate of $57.8M.
Browse earnings estimates, EPS, and revenue on all stocks.